Mitra S, Chen B, Shelton J, Nitschke S, Wu J, Covington L
Acta Neuropathol. 2024; 147(1):46.
PMID: 38411740
DOI: 10.1007/s00401-024-02698-x.
Desdentado L, Espert R, Sanz P, Tirapu-Ustarroz J
Rev Neurol. 2019; 68(2):66-74.
PMID: 30638256
PMC: 6531605.
Inayat F, Ullah W, Lodhi H, Khan Z, Ilyas G, Ali N
Cureus. 2018; 10(8):e3197.
PMID: 30498646
PMC: 6257626.
DOI: 10.7759/cureus.3197.
Sathiah P, Gochhait D, Dehuri P, Subramanian H
J Clin Diagn Res. 2017; 11(9):EJ01-EJ02.
PMID: 29207724
PMC: 5713746.
DOI: 10.7860/JCDR/2017/28570.10552.
Sullivan M, Nitschke S, Steup M, Minassian B, Nitschke F
Int J Mol Sci. 2017; 18(8).
PMID: 28800070
PMC: 5578133.
DOI: 10.3390/ijms18081743.
Lafora disease.
Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley C
Epileptic Disord. 2016; 18(S2):38-62.
PMID: 27702709
PMC: 5777303.
DOI: 10.1684/epd.2016.0842.
Neuronatin-mediated aberrant calcium signaling and endoplasmic reticulum stress underlie neuropathology in Lafora disease.
Sharma J, Mukherjee D, Rao S, Iyengar S, Shankar S, Satishchandra P
J Biol Chem. 2013; 288(13):9482-90.
PMID: 23408434
PMC: 3611017.
DOI: 10.1074/jbc.M112.416180.
Early-onset Lafora body disease.
Turnbull J, Girard J, Lohi H, Chan E, Wang P, Tiberia E
Brain. 2012; 135(Pt 9):2684-98.
PMID: 22961547
PMC: 3437029.
DOI: 10.1093/brain/aws205.
Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.
Hashmi M, Saleem F, Mustafa M, Sheerani M, Ehtesham Z, Siddiqui K
BMJ Case Rep. 2012; 2010.
PMID: 22791845
PMC: 3030305.
DOI: 10.1136/bcr.01.2010.2653.
Genetics of inherited human epilepsies.
Gourfinkel-An I, Baulac S, Brice A, Leguern E, Baulac M
Dialogues Clin Neurosci. 2011; 3(1):47-57.
PMID: 22034131
PMC: 3181638.
Lafora disease: epidemiology, pathophysiology and management.
Monaghan T, Delanty N
CNS Drugs. 2010; 24(7):549-61.
PMID: 20527995
DOI: 10.2165/11319250-000000000-00000.
Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease.
Rao S, Sharma J, Maity R, Jana N
J Biol Chem. 2009; 285(2):1404-13.
PMID: 19892702
PMC: 2801266.
DOI: 10.1074/jbc.M109.006312.
Novel mutation in the NHLRC1 gene in a Malian family with a severe phenotype of Lafora disease.
Traore M, Landoure G, Motley W, Sangare M, Meilleur K, Coulibaly S
Neurogenetics. 2009; 10(4):319-23.
PMID: 19322595
PMC: 2758214.
DOI: 10.1007/s10048-009-0190-4.
The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease.
Gentry M, Dowen 3rd R, Worby C, Mattoo S, Ecker J, Dixon J
J Cell Biol. 2007; 178(3):477-88.
PMID: 17646401
PMC: 2064834.
DOI: 10.1083/jcb.200704094.
Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates.
Worby C, Gentry M, Dixon J
J Biol Chem. 2006; 281(41):30412-8.
PMID: 16901901
PMC: 2774450.
DOI: 10.1074/jbc.M606117200.
Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.
Gentry M, Worby C, Dixon J
Proc Natl Acad Sci U S A. 2005; 102(24):8501-6.
PMID: 15930137
PMC: 1150849.
DOI: 10.1073/pnas.0503285102.
Identification of a recombination event narrowing the Lafora disease gene region.
Maddox L, Descartes M, Collins J, Keating J, Rosenfeld S, Palmer C
J Med Genet. 1997; 34(7):590-1.
PMID: 9222970
PMC: 1051002.
DOI: 10.1136/jmg.34.7.590.
Progressive myoclonic epilepsy (Unverricht type) with atypical Lafora bodies. Case report.
Grahmann F, Janzer R, Hecker A, Egli M, Burger P
Eur Arch Psychiatry Neurol Sci. 1986; 235(4):259-62.
PMID: 3009199
DOI: 10.1007/BF00379982.
Polyglucosan bodies in intramuscular motor nerves.
Bernsen R, Busard H, ter Laak H, Gabreels F, Renier W, Joosten E
Acta Neuropathol. 1989; 77(6):629-33.
PMID: 2546356
DOI: 10.1007/BF00687891.
Early detection of skin and muscular involvement in Lafora disease.
Iannaccone S, Zucconi M, Quattrini A, Nemni R, Comola M, Taccagni L
J Neurol. 1991; 238(4):217-20.
PMID: 1654400
DOI: 10.1007/BF00314784.
